The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 29, 2015

Filed:

Jan. 26, 2012
Applicants:

Jin Woo Lee, Goyang-si, KR;

Min Sung Park, Seoul, KR;

Yun Hee Kim, Seoul, KR;

Inventors:

Jin Woo Lee, Goyang-si, KR;

Min Sung Park, Seoul, KR;

Yun Hee Kim, Seoul, KR;

Assignee:

Tego Science Inc., Seoul, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/54 (2006.01); A61L 27/18 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61L 27/56 (2006.01); A61L 27/58 (2006.01); C07K 14/52 (2006.01); C07K 14/54 (2006.01); C07K 17/02 (2006.01);
U.S. Cl.
CPC ...
A61K 38/2053 (2013.01); A61K 38/195 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61L 27/58 (2013.01); C07K 14/523 (2013.01); C07K 14/5421 (2013.01); C07K 17/02 (2013.01); A61L 2300/252 (2013.01); A61L 2300/412 (2013.01); A61L 2430/24 (2013.01);
Abstract

The present invention relates to an implantable composition for treating a damaged tissue and a method for inducing an in vivo migration of a cell for treatment to a damaged tissue region. The present invention treats the damaged tissue by inducing/promoting homing of a cell for tissue generation by implanting a biodegradable scaffold reacted with chemotactic factors (for example, IL-8 or MIP-3α) to a damaged location (for example, joint cartilage or skin). Thus, the composition of the present invention can not only be applied to the treatment of a damaged bone tissue, a joint cartilage, or a skin tissue more conveniently and efficiently compared to the conventional technology, but can also be used as a useful treatment supplement agent in cell treatment using allogeneic cell by enabling efficient utilization of cell resources for treatment, the cell resources which are high in scarcity.


Find Patent Forward Citations

Loading…